A novel founder MSH2 deletion in Ethiopian Jews is mainly associated with early-onset colorectal cancer

I. Kedar, L. Walsh, G. Reznick Levi, S. Lieberman, A. Abu Shtaya, S. Naftaly Nathan, I. Lagovsky, R. Tomashov-Matar, M. Goldenberg, L. Basel-Salmon, L. Katz, O. Aleme, T. Yablonski Peretz, A. Hubert, D. Rothstein, S. Castellvi-Bel, T. Walsh, M. C. King, C. C. Pritchard, Z. LeviE. Half, I. Laish, Y. Goldberg*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'A novel founder MSH2 deletion in Ethiopian Jews is mainly associated with early-onset colorectal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences